Guaifenesin Tablet, Extended Release
Product Images NDC 30142-961

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Guaifenesin (NDC 30142-961). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Kroger Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (20 Tablets Blister Pack Carton)

Principal Display Panel (20 Tablets Blister Pack Carton)
The packaging label for GUAIFENESIN Mucus Relief ER with 600 mg extended-release guaifenesin tablets, marketed as an expectorant by Kroger Company. The box contains 20 extended-release tablets, providing 12-hour relief. The label includes directions, warnings, inactive ingredients, and contact information for questions, stating the product is distributed by Kroger Co. in Cincinnati, Ohio.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.